Cargando…
The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
Exposure to aristolochic acid (AA) is associated with human nephropathy and urothelial cancer. The tumour suppressor TP53 is a critical gene in carcinogenesis and frequently mutated in AA-induced urothelial tumours. We investigated the impact of p53 on AAI-induced nephrotoxicity and DNA damage in vi...
Autores principales: | Sborchia, Mateja, De Prez, Eric G., Antoine, Marie-Hélène, Bienfait, Lucie, Indra, Radek, Valbuena, Gabriel, Phillips, David H., Nortier, Joëlle L., Stiborová, Marie, Keun, Hector C., Arlt, Volker M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823306/ https://www.ncbi.nlm.nih.gov/pubmed/31602497 http://dx.doi.org/10.1007/s00204-019-02578-4 |
Ejemplares similares
-
Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone
por: Arlt, Volker M., et al.
Publicado: (2016) -
Cytochrome b(5) impacts on cytochrome P450-mediated metabolism of benzo[a]pyrene and its DNA adduct formation: studies in hepatic cytochrome b(5)/P450 reductase null (HBRN) mice
por: Reed, Lindsay, et al.
Publicado: (2018) -
Mutagenicity of acrylamide and glycidamide in human TP53 knock-in (Hupki) mouse embryo fibroblasts
por: Hölzl-Armstrong, Lisa, et al.
Publicado: (2020) -
Benzo[a]pyrene and Caenorhabditis elegans: defining the genotoxic potential in an organism lacking the classical CYP1A1 pathway
por: Abbass, Mustafa, et al.
Publicado: (2021) -
Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene
por: Long, Alexandra S., et al.
Publicado: (2017)